Moors & Cabot’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$245K Sell
1,517
-4,297
-74% -$693K 0.01% 721
2025
Q1
$989K Sell
5,814
-5,047
-46% -$859K 0.05% 324
2024
Q4
$1.81M Buy
10,861
+1,158
+12% +$192K 0.09% 201
2024
Q3
$1.67M Buy
9,703
+374
+4% +$64.3K 0.08% 217
2024
Q2
$1.44M Buy
9,329
+595
+7% +$91.6K 0.08% 230
2024
Q1
$1.34M Buy
8,734
+365
+4% +$56.1K 0.07% 240
2023
Q4
$1.32M Buy
8,369
+314
+4% +$49.6K 0.08% 234
2023
Q3
$1.18M Buy
8,055
+264
+3% +$38.6K 0.08% 226
2023
Q2
$1.19M Sell
7,791
-81
-1% -$12.4K 0.08% 240
2023
Q1
$1.22M Sell
7,872
-41
-0.5% -$6.36K 0.08% 237
2022
Q4
$1.22M Buy
7,913
+848
+12% +$131K 0.09% 237
2022
Q3
$932K Buy
7,065
+109
+2% +$14.4K 0.07% 266
2022
Q2
$943K Buy
6,956
+795
+13% +$108K 0.07% 283
2022
Q1
$919K Buy
+6,161
New +$919K 0.06% 312
2018
Q2
Sell
-9,062
Closed -$1.2M 569
2018
Q1
$1.2M Buy
9,062
+1,845
+26% +$245K 0.16% 156
2017
Q4
$896K Sell
7,217
-320
-4% -$39.7K 0.12% 201
2017
Q3
$933K Buy
7,537
+167
+2% +$20.7K 0.13% 179
2017
Q2
$841K Buy
7,370
+3,952
+116% +$451K 0.14% 186
2017
Q1
$361K Sell
3,418
-3,195
-48% -$337K 0.06% 344
2016
Q4
$600K Sell
6,613
-441
-6% -$40K 0.1% 244
2016
Q3
$703K Sell
7,054
-3,299
-32% -$329K 0.12% 207
2016
Q2
$927K Sell
10,353
-2,046
-17% -$183K 0.16% 156
2016
Q1
$1.09M Sell
12,399
-540
-4% -$47.3K 0.2% 131
2015
Q4
$1.46M Buy
+12,939
New +$1.46M 0.27% 102